Citi raised the firm’s price target on Universal Health to $193 from $170 and keeps a Buy rating on the shares following the Q4 report. The analyst says Acute is benefiting from strong volumes and solid pricing as mix pressures stabilized. The firm expects the stock to “grind higher.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on UHS:
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND 2024 OPERATING RESULTS FORECAST
- Universal Health sees FY24 CapEx $850M-$1B
- Universal Health sees FY24 adjusted EPS $13.00-$14.00, consensus $11.75
- Universal Health reports Q4 adjusted EPS $3.13, consensus $2.88
- Notable companies reporting after market close